This funding opportunity supports international preclinical and clinical research projects aimed at slowing, stopping, or reversing Parkinson’s disease by focusing on disease modification. Preclinical projects must have a clinical candidate and a feasible timeline to clinical testing. Clinical trials must involve people with Parkinson’s and exclude trials with only healthy volunteers. Funding amounts vary by project type, with a two-stage application process and quarterly reviews.
Applications are accepted internationally from academics and commercial entities, alone or in collaboration. Clinical projects must involve people with Parkinson's; trials involving only healthy volunteers are not funded. Applicants must comply with grant terms and conditions.
